News Focus
News Focus
icon url

HDGabor

05/10/14 10:18 AM

#27380 RE: BioChica #27379

It will not happan:

a.) wsc is not $168, it's app. $126. The real sales was around 9,6M in Q1 since 10,9M inc. the deferred revenue from previous Q.

b.) KOWA will start end of May / begining of June. "Kowa team should be before the end of this month be fully trained out and promoting Vascepa"

c.) It takes time to them to reach at least the same script level / sales person as the current sales team. "So we anticipate that it will take Kowa multiple calls before they have a major impact relative to prescription writing and maybe a little bit different than normal on the sense that some of these doc have been called on by Amarin in the past, albeit, multiple months back at this juncture. We're not prepared to quantify the extent of their impact. But we would anticipate that, that impact will be increasing throughout the second half of this year and then accelerating beyond that in years going forward"
icon url

invest2992

05/10/14 12:21 PM

#27383 RE: BioChica #27379

That is a steep curve, what are the odds?
icon url

invest2992

05/10/14 5:02 PM

#27397 RE: BioChica #27379

If 7000 scripts/wk = $1.50/share, will 12,500scripts/wk in mid-July = $2.70 / share? And 22,000 scripts/ week at year end = $4.75 a share at year end!!!
icon url

Biobillionair

05/10/14 11:57 PM

#27411 RE: BioChica #27379

I agree and the first week they're off this target I sell and put that money towards destroying the Cartel that royally fuck Amarin over!